
Get answers to your heart disease prevention questions.
Dr. Miller’s Bio | Q&A Archive
Ischemic heart disease; Cardiomyopathy - ischemic
The goal of treatment is to relieve symptoms and treat the cause of the condition. If symptoms are severe, you may need to stay in the hospital.
A cardiac catheterization will be done to see if you can have bypass surgery or a balloon procedure (angioplasty). These treatments can improve blood flow to the damaged or weakened heart muscle.
The overall treatment of cardiomyopathies is focused on treating heart failure.
See also: Heart failure
Drugs and treatments that may be used include:
Some people may benefit from the following heart devices:
A low-salt diet may be prescribed for adults. Fluid may be restricted in some cases. You can usually continue your regular activities, if you are able.
If you smoke or drink alcohol excessively, stop doing so. These habits increase stress on the heart.
You may be asked to monitor your body weight daily. Weight gain of 3 or more pounds over 1 or 2 days may indicate fluid buildup (in adults).
A heart transplant may be recommended for patients who have failed all the standard treatments and still have very severe symptoms. Recently, implantable, artificial heart pumps have been developed. However, very few patients are able to undergo either of these advanced treatments.
This is a very serious disorder. It is a chronic illness that usually gets worse over time. Infection and other stress on your body from other medical illnesses will also cause symptoms to get worse.
It is very important to discuss your situation with your doctor to ensure that you can improve it as much as possible. You can control symptoms of heart failure and angina with medication, lifestyle changes, and by treating any underlying disorder.
Go to the emergency room or call 911 if:
Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guidelines Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235.
Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
Hare JM. The dilated, restrictive, and infiltrative cardiomyopathies. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa; Saunders Elsevier;2007:chap 64.